Session » 6W010 ACR Abstract: SLE–Clinical V: Biomarkers, Criteria, & Outcomes (2928–2933)
- 9:00AM-10:30AM
-
Abstract Number: 2931
Missing Outcomes in SLE Clinical Trials: Impact on Estimating Treatment Effects
- 9:00AM-10:30AM
-
Abstract Number: 2933
Non-Invasive Tape Sampling Reveals RNA Gene Clusters in Cutaneous Lupus Erythematosus That Discriminate Affected from Unaffected and Healthy Volunteer Skin
- 9:00AM-10:30AM
-
Abstract Number: 2930
Prospective Comparison of Remission and Lupus Low Disease Activity State – Effect on Disease Outcomes in Systemic Lupus Erythematosus
- 9:00AM-10:30AM
-
Abstract Number: 2932
Systemic Lupus Erythematosus Biomarkers Identified Using Multi-Omic and Artificial Intelligence Analysis through Interrogative Biology
- 9:00AM-10:30AM
-
Abstract Number: 2928
Validation of New Systemic Lupus Erythematosus Classification Criteria
- 9:00AM-10:30AM
-
Abstract Number: 2929
Validation of Remission and Lupus Low Disease Activity State As Predictors of Organ Damage in SLE